Deborah Neff has experience in building businesses and product commercialisation in life sciences industry. She is advising several early-stage companies developing innovative technology to improve patient care.
Ms Neff remains as the principal of a privately-held consulting company DJN Consulting, which she formed in 2013.
Ms Neff was the chief executive of Evanostics, a development stage company focused on systems for applications in point-of-care diagnostic testing in forensic and clinical toxicology. Prior to that, she was the chief operating officer of Complete Genomics which is a life sciences company in whole genome and exome sequencing, chief operating officer of Pathwork Diagnostics, and chief executive of Predicant Biosciences.
Ms Neff was also the global president of BD Biosciences, a major business segment of Becton Dickinson and Company until 2003. Her 15-year tenure included various management positions as general manager, vice president and director of several business areas.
Ms Neff's work in life sciences has included the areas of cancer diagnostics, immunocytometry and genomics, having establishing a certified clinical laboratory, guiding a molecular diagnostic test through the FDA clearance process, securing reimbursement pathways, and building commercial pipelines.
She completed executive programs in Marketing, Finance, Operations and Management at UCLA, Wharton, Stanford, and Harvard business schools.
